tradingkey.logo

LENSAR Inc

LNSR
View Detailed Chart

12.610USD

-0.280-2.17%
Close 08/01, 16:00ETQuotes delayed by 15 min
148.67MMarket Cap
LossP/E TTM

LENSAR Inc

12.610

-0.280-2.17%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.17%

5 Days

-3.37%

1 Month

-4.18%

6 Months

+18.40%

Year to Date

+41.05%

1 Year

+153.21%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
HOLD
Current Rating
15.000
Target Price
18.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

95
Total
4
Median
7
Average
Company name
Ratings
Analysts
LENSAR Inc
LNSR
2
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(2)
Buy(1)
Indicators
Sell(4)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.061
Neutral
RSI(14)
40.504
Neutral
STOCH(KDJ)(9,3,3)
34.148
Sell
ATR(14)
0.287
High Vlolatility
CCI(14)
-298.263
Oversold
Williams %R
71.806
Sell
TRIX(12,20)
0.050
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
12.994
Sell
MA10
13.050
Sell
MA20
13.054
Sell
MA50
13.033
Sell
MA100
13.598
Sell
MA200
11.047
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
Ticker SymbolLNSR
CompanyLENSAR Inc
CEOMr. Nicholas T. (Nick) Curtis
Websitehttps://www.lensar.com/
KeyAI